L12 ´³°¨³½¿ò¶Ç¹êÅç«Ç

Zebrafish Genetics Laboratory

 

¹êÅç«Ç¥D«ù¤H¡G½²´f¬Ã

¨ó¦P¥D«ù¤H¡G¶À»Í¬Ã

³ü¡B­I´º¸ê®Æ

¤@¡B³]¸m½t¥Ñ

°ò¦]­pµe¦b¶§©ú¤j¾Ç¤w°õ¦æ¼Æ¦~¡A¨Ã¦b¦hºØÀù²Õ´¤¤¿z¿ï¤F±µªñ4,000ºØ¨ã²§±`ªí²{ªº°ò¦]¡CÁöµMÅé¥~°ö¾iªº²Ó­M¯à¦b³J¥Õ½èªº¥\¯à¤W´£¨Ñ³¡¤Àªº°T®§¡A¦ý°Êª«¼Ò¦¡¤~¬O³J¥Õ½è¦b¬¡Å餺µo´§¥\¯àªº§¹¾ã¼Ò¦¡¡C¥Ø«e¤p¹«¬O­÷¨Å°Êª«¤¤³Ì²z·Qªº¹êÅç°Êª«¡A¦ý¨äÅ餺¨üºë¡AÅ餺µo¨|ªº¯S©Ê¥O³\¦h­F­L¦­´Á§Y»Ýµo´§¥\¯àªº³J¥Õ½è¦bgain of function¤Îloss of functionªº±¡ªp¤UµLªk¶¶§QªºµÛ§Éµo¨|¡C¦Ó´³°¨³½ªº­F­Lµo¨|¤Wªº¾÷¨î»P­÷¨Å°Êª«¬O«D±`¬Û¦ü¡A³\¦h­«­nªº½Õ±±³J¥Õ½èªºªí²{¦ì¸m»P®É¶¡¤]³£»P­÷¨Å°Êª«¬Û¦ü¡A¥Ñ©ó´³°¨³½­F­L¼Æ¶q·¥¦h¡AÅé¥~±ÂºëÅé¥~¹å¤Æ¥B­FÅé§¹¥þ³z©ú¡A¯«¸g¡B¦Ù¦×¡B¤ßŦ¡B¦åºÞ¡B¦å²y¦b¥i¨£¥úÅã·LÃè²M´·²M·¡¡C¨üºë§Z³æ²Ó­M¦b48¨ì72¤p®É«á§Yµo¨|¦¨¥i³V­¹°k¤`ªº³½Åé¡Cºë¤l¥i¸g¥ÑNEU chemical mutagenesis¶i¦æ¬ðÅܺتº¿z¿ï¡C³æ²Ó­M¨üºë§Z¥i¬I¥´DNA¡BRNA¨Ã±K¤Á°lÂÜ«áÄòªº¼vÅT¡A¦]¦¹´³°¨³½¤w¦¨¬°¬ã¨sÀù¯g¡B¤ß¦åºÞ¯e¯f¡B¾¹©xµo¨|¡B¯á´Õ°Êª«­F­Lµo¨|¡B¯«¸gµo¨|¡B²Ó­M­ä¤`ªº­«­n¼Ò¦¡¡A¦bÃĪ«¬r©Êªº¿zÀˤ]§êºt­«­n¨¤¦â¡C

 

¤G¡B®Ö¤ß§Þ³N²¤¶

1¡BDNAÅã·Lª`®g

±N100~200 ng/2 plªºlinearlized DNAª`®g³æ²Ó­M¨üºë§Zªº²Ó­M½è¤¤¡A¶i¦æ±Ò°Ê¤l½Õ±±¾÷¨î¤§¬ã¨s©Îµu´Á¤j¶qªí¹F¥¼ª¾¥\¯à°ò¦]¥Hin vivoªº¤è¦¡¬ã¨s¨ä¥i¯à¥\¯à¡C¥Ñ©ó¨üºë§ZÅé¿nºÓ¤j¦]¦¹¦b¸Ñ­åÅã·LÃè¤Uª`®gDNA¨ì¨üºë§Zªº°Ê§@¥i¥H§Ö³t¶i¦æ¡A¥H300~400­Ó¬I¥´¹LDNA­F­Lªºphenotype¨Ó¥Nªíª`®gDNAªº¥\¯à¬O¨ã¦³¬Û·í°ª¥i«H«×¡C                                             

2¡BRNAÅã·Lª`®g

¸ÕºÞ¦X¦¨ªºmRNA (with 5ºÝCAP¤Î3ºÝpoly A) ªº§¹³Æµ²ºc¥iª½±µª`®g¨ì´³°¨³½ªº¨üºë§Z§Z¶Àªº³¡¤À¡A¦A¸g¥Ñ§Z¶À»P²Ó­Mª«½è¤¬´«ªºµ{§Ç±NmRNA§¡¤Ãªº¤À¥¬©ó¦h²Ó­Mªº­F­L¡CmRNAÂàͦ¨³J¥Õ½è«á§Y¥iµo´§¥\¯à¡A¥i©ó­F­Lªºµo¨|¹Lµ{¤¤Æ[¹î¨ä¥\¯à¡C¥Ñ©ómRNA´X¥G¥i¹M§G³½Åé©Ò¦³²Õ´¡A¨ã¦³§Ö³t¿zÀ˳J¥Õ½è¥¼ª¾¥\¯àªºÀuÂI¡C

3¡BAntisense morpholino oligomerÅã·Lª`®g

°£¤F¤j¶qªí²{¥¿±`³J¥Õ½è©Î¬ðÅܳJ¥Õ½è¥~¡A¥t¤@ºØµ{«×©ÊKnock-down°ò¦]ªí²{ªº¤èªk¬OÂǥѤƾǩʬ۷íí©wªºantisense morpholino oligomer¨Ó¹F¦¨¡C¥u­n¨Ì¾ÚATG¤W´å¤U´å¦U10­Ó®Ö»Ä§Ç¦C¦X¦¨oligomer¡A§Y¥i­É¥Ñª`®g¶qªº±±¨î¹F¨ìµ{«×©Ê¦a¼vÅT¼Ðªº³J¥Õ½è¥Í¦¨¶q¡A¶i¦Ó¤Þµo¤£µ{«×©Ê¤zÂZ­«­n³J¥Õ½èªº¥Øªº¡A¦b­F­Lµo¨|¹Lµ{¤¤Á×§KÄY­«¤zÂZ­«­n³J¥Õ½è¤Þ°_ªº­P©R©Ê¡C

4¡B°ò¦]Âà´Þ³½stable lineªº«Ø¥ß

°ò¦]Âà´Þ³½´£¨Ñ¤@­Óí©wªí²{³J¥Õ½è¨Ã¥i­«ÂШϥΪº°Êª«¼Ò¦¡¡A¥Ñ©óadeno associated virus ITR§Ç¦C¥i¼W¥[chromosome insertionªº¾÷²v¦Ü20%¡A´£°ª«Ø¥ßstable lineªº¾÷²v¡A¥Ñ©ó¯Z°¨³½¥N»P¥N¤§¶¡¶È»Ý3­Ó¤ë¡A¦]¦¹³o¬O¤@­Ó§Ö³t«Ø¥ß¹êÅç°Êª«¼Ò¦¡ªº¤èªk¡C

5¡BNEU point mutagenesis

NEUªº¿@«×±±¨î¼vÅT¬ðÅܺتº«~½è¡A±±¨îNEU¦b²z·Qªº½d³ò¥i²£¥Í¨C­Ó°ò¦]single point mutationªº¬ðÅܺءA¥Ñ©ó´³°¨³½§Ö³tµo¨|¦¨¼ôªº¯S©Ê¡ANEUªº¬ðÅܤèªk¥i¥H¥Î¨Ó¿z¿ï¥O¬ã¨sªÌ·P¿³½ìphenotypeªº¬ðÅܺءC

 

¤T¡BªÅ¶¡

Åã·Lª`®g³]³Æ©ñ¸m¦bÅ@²zÀ]¤j¼Ó211«Ç¡A¾i³½³½©Ð³]¦b210«Ç¡Aªø3.5¦Ì¼e2.5¦Ì¡A°t¸m¥|­Ó¤­¼h°ª¤£ù׿û¬[³½¬û¡A±Ä¶}©ñºw¬yªº¤ô¬y¥´®ð´`Àô¨t²Î¡A¨ã³Æ¥ú¶g´Á¡B28¢J«í·Å¡B24¤p®É¨Ñ¤ô³]¬I¡C

 

¥|¡B¤H­û

²Ä¤@¦~­Ý¥ô¬ã¨s§U²z¤@¦W­t³d´³°¨³½±Æ§Z¡AºûÅ@³½©Ð²M¼ä¡C¥»¹êÅç¥Ñ¤¤¥¡¬ã¨s°|¥Í¤Æ¬ã¨s©Ò¶À»Í¬Ã°Æ¬ã¨s­û¨ó¦P¥D«ù¡C

 

¶L¡B³]¬I³W¹º»P»¡©ú

¤@¡B²{¦³»ö¾¹

ªoÀ£¦¡Åã·Lª`®g¾¹

Leica¸Ñ­åÅã·LÃè

·Å±±¥ú¶g´Á°ö¾i½c

¤G¡B¹w­pÂX¥R¤§³]³Æ

²Ä¤@¦~

1¡B³]¸m³½©Ð¡A¬[³]¶}©ñ¦¡¤ô¬y¤Î¥´®ð¨t²Î

2¡BZeiss¥¿¥ß¦¡Åã·LÃè (Axioplan 2)

3¡BÅã·LÃè¿Ã¥ú³]³Æ¤@²Õ

4¡B®ðÀ£¦¡Åã·Lª`®g¾¹

²Ä¤G¦~

1¡B©Ô°w¾¹

2¡B¿i°w¾¹

3¡BÄá¼v¨t²Î¤Î¤ÀªR³nÅé¤@®M (AxioCam, Axioversion)

 

°Ñ¡B±`³WªA°È

¤@¡BDNA½èÅéÅã·Lª`®g

¤j¶qªí²{³J¥Õ½è©ó¯S©w²Õ´¤¤¡A­É¥Ñ¯«¸g¡B¤ßŦ¡B¨x¡B¥Ö½§µ¥¯S²§©Ê²Õ´¯S²§©Ê¤§±Ò°Ê¤l¡A±Ò°Ê¥¼ª¾¥\¯à³J¥Õ½è©ó¤W­z¾¹©x¤¤ªí²{¡A¥H´³°¨³½§@in vivoªº¥\¯à©Ê¬ã¨s¡A§Q¥Î³½Åé³z©úªº¯S©Ê¥i¸g¥Ñ¥i¨£¥úÅã·LÃè§Y¥iÀò±oªì¨B¤j¶q¿z¿ïªºµ²ªG¡A¥Ó½ÐªÌÀ³´£¨Ñ¤§§÷®Æ¬O«Øºc¦nªº¯u®Öªí²{³J¥Õ½èÅé¡C¦UºØrestriction enzyme¤Á³Î½T©w¤§µ²ªG¸ê®Æ¡A¤ÎDNA sequencing½T»{½èÅ饿½T©Ê¡C³Æ»slinearized targeting vector (¬ù20£gg)¡A¤ÎphotographÃÒ©úlinearized targeting vector¤§«~½è»P©w¶q¡C¦³Ãö±Ò°Ê¤lªº¬ã¨s¡A´³°¨³½¹êÅç«Ç±N´£¨Ñ¸üÅ餩¥Ó½ÐªÌ¶i¦æ¥H¤ô¥Àºñ¦â¿Ã¥ú³J¥Õ½èªºªí²{¨Ó¥Nªí±Ò°Ê¤lªº¥\¯à¡C

 

¤G¡BRNAÅã·Lª`®g

¦b­F­Lµo¨|¹Lµ{¤¤¡A§Z¶À»P²Ó­M½è¦s¦³§Ö³t¤¬´«¤À¤lªººÞ¹D¡A§Q¥ÎmRNAª½±µª`®g§Ú­Ì¥i¹F¦¨¥þ¨­©ÊÆ[¹î³J¥Õ¥\¯àªº®ÄªG¡A¦X¾A¶i¦æin vitro transcription DNA¸üÅé±N¥Ñ¥»´³°¨³½¹êÅç«Ç´£¨Ñ¡A¥Ó½ÐªÌÀ³¥HDNA  restriction enzyme¤Á¹Lªº½u©ÊDNA½èÅé¼ÒªO¡A¦X¦¨in vitro transcriptionÂà¿ý¦¨mRNA¡A§¹¦¨mRNAªº©w¶q¤Î¹qªa·Ó¬Û¡C

 

¤T¡BAntisense morpholino oligomerª`®g

Morpholino¦b´³°¨³½À³¥Îªº¦¨¥\²v¬Û·í°ª¡A°w¹ïATGªþªñªº§Ç¦C¦X¦¨antisense¡A¥HÅã·L§Þ³N¥´¶i³æ²Ó­M¡A§Y¥iin vivoÆ[¹î¦¹¯S©w°ò¦]³Q¤£¦Pµ{«×©Êknock downªº«áÄòphenotype¡C¥Ó½Ð¤HÀ³´£¨Ñ¥Ñ±M·~¤½¥qµû¦ô«ØÄ³¦X¦¨ªºoligomer 10 £gg¡C

¥Ó½Ð¤H¹w´Á±o¨ìªºªA°È

 

1¡B´£¨ÑCMV enhancer¤Î¥Ö½§¡B¤ßŦ¡B¨xŦ¡B¯«¸g¯S²§©Ê±Ò°Ê¤lÅX°Êªº½èÅé¡A¥H§Q¸m¤J¬ã¨sªÌ¦³¿³½ì³J¥ÕªºcDNA¡A°£¤FCMV enhancer¡AKeratine-8¥Ö½§±Ò°Ê¤l¤§¥~¨Ï¥Î¨ä¥L²Õ´¯S²§©Ê±Ò°Ê¤l (¦pBMP4, Nav1.6µ¥±Ò°Ê¤l) »Ý»P¨Æ¥ý¨ú¨Ñ´£¨Ñ¸Ó±Ò°Ê¤l¤§¹êÅç«Ç¦P·N¡C

2¡B´£¨Ñin vitro transcription©Ò»Ý½èÅ餺§tSP6, T3, ¤ÎT7 RNA»E¦X»Ã¯Àµ²¦X§Ç¦C¡C

3¡B´£¨ÑDNA and RNA transient overexpression¤Îmorpholino knock-downªº°ò¦]Âà´Þ³½¡C

 

¯Z°¨³½¹êÅç«Ç±N§¹¦¨300-400­Ó¨üºë§Zªºª`®g¡A24-48¤p®É«á¨Ã·|¦P¥Ó½ÐªÌ¨Ï¥Î«p¤ù²Õ´±M¥ÎªºAxioplan 2Åã·LÃè¶i¦æ¥i¨£¥úªºÆ[¹î¡A­Y»Ý¥H¿Ã¥ú§K¬Ì¬V¦â¶i¦æ²Ó³¡¤ÀªR¡A´³°¨³½¹êÅç«Ç¥ç´£¨Ñ«p¤ù²Õ´±M¥Îªº¿Ã¥úÅã·LÃè¡C

 

¥|¡B¹w¦ô¨Ï¥Î¸g¶O

ªA°È©Ò»Ý¶O¥Î½Ð°Ñ¦Ò: http://genome.ym.edu.tw

 

¤­¡BªA°È¯à¶q

²Ä¤@¦~Åã·Lª`®g50­Ó°ò¦]

 

¤»¡B«D±`³WªA°È¤§¦X§@¬ã¨s

«D¥~Æ[µo¨|¥iÆ[¹î¨ìªº®ÄªG¡A»ÝÂǥѶi¤@¨BÂø¥æ¬V¦âªk´M§äphenotypeªÌ¡A»Ýµø­Ó§O°ò¦]¥\¯à³]©w¥i¯àªºphenotype¶i¤@¨B¬ã¨sªÌ½Ð»P¥D«ù¤H·|°Ó¡C

 

¤C¡B­t³d±Ð±Â

¶§©ú¤j¾Ç¯«¬ã©Ò ½²´f¬Ã°Æ±Ð±Â

¤¤¥¡¬ã¨s°|¥Í¤Æ©Ò ¶À»Í¬Ã°Æ¬ã¨s­û

 

¤K¡BÁpµ¸»PÁpµ¸¤èªk

¶§©ú¤j¾Ç¯«¬ã©Ò ½²´f¬Ã°Æ±Ð±Â

Tel¡G02-2826-7154¡FFax¡G02-2820-0259¡Fe-mail¡Ghjtsay@ym.edu.tw

 

¤E¡B§Þ³N°V½m»P±À¼s¬¡°Ê

¨C¦~¤ä´©¤Î°Ñ¥[¶§©ú°ò¦]Åé¬ã¨s¤¤¤ß©ÒÁ|¿ìªº¬ã°Q·|¡C

 

¦^¥Ø¦¸

¡i ¦^°ò¦]Å餤¤ß¤¤¤å­º­¶ ¡j ¡@¡i ¦^´³°¨³½¿ò¶Ç¾Ç¹êÅç«Ç ¡j ¡@¡i µ¹¥»¹êÅç«Çªº·N¨£ ¡j


Copyright (C) Since 2000. Yang-Ming University, All rights reserved

Last update: Oct 7, 2003